(2R)-2-{3-[3-(4-Methoxybenzoyl)-2-methyl-6-(trifluoromethoxy)-1H- indol-1-yl]phenoxy}butanoic acid
Modify Date: 2022-09-16 18:03:46
![(2R)-2-{3-[3-(4-Methoxybenzoyl)-2-methyl-6-(trifluoromethoxy)-1H- indol-1-yl]phenoxy}butanoic acid Structure](https://image.chemsrc.com/caspic/427/668455-28-5.png)
(2R)-2-{3-[3-(4-Methoxybenzoyl)-2-methyl-6-(trifluoromethoxy)-1H- indol-1-yl]phenoxy}butanoic acid structure
|
Common Name | (2R)-2-{3-[3-(4-Methoxybenzoyl)-2-methyl-6-(trifluoromethoxy)-1H- indol-1-yl]phenoxy}butanoic acid | ||
|---|---|---|---|---|
| CAS Number | 668455-28-5 | Molecular Weight | 527.48800 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C28H24F3NO6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of (2R)-2-{3-[3-(4-Methoxybenzoyl)-2-methyl-6-(trifluoromethoxy)-1H- indol-1-yl]phenoxy}butanoic acidMK-0533 is a novel PPARγ partial agonist for the prevention of vascular endothelial dysfunction (VED) and VED-related cardiovascular disease. |
| Name | (2R)-2-{3-[3-(4-Methoxybenzoyl)-2-methyl-6-(trifluoromethoxy)-1H- indol-1-yl]phenoxy}butanoic acid |
|---|
| Description | MK-0533 is a novel PPARγ partial agonist for the prevention of vascular endothelial dysfunction (VED) and VED-related cardiovascular disease. |
|---|---|
| References | 1. Acton JJ 3rd, et al. Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic acid (MK-0533): a novel selective peroxisome proliferator-activated receptor gamma modulator for the treatment of type 2 diabetes mellitus with a reduced potential to increase plasma and extracellular fluid volume. J Med Chem. 2009 Jul 9;52(13):3846-54. |
| Molecular Formula | C28H24F3NO6 |
|---|---|
| Molecular Weight | 527.48800 |
| Exact Mass | 527.15600 |
| PSA | 86.99000 |
| LogP | 6.31910 |